A notable advancement in glucose management is emerging with the release of tirzepatide in a 45mg form. This innovative formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://socialbaskets.com/story6991864/significant-introduction-tirzepatide-45mg-for-diabetes-control